Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5303]

Cancer cells that spread to different sites in the body express varying levels of targetable proteins

Cancer cells that spread to different sites in the body express varying levels of targetable proteins

Axi-cel proves effective as first-line treatment for high-risk lymphoma

Axi-cel proves effective as first-line treatment for high-risk lymphoma

FDA approves nivolumab and relatlimab-rmbw for unresectable or metastatic melanoma

FDA approves nivolumab and relatlimab-rmbw for unresectable or metastatic melanoma

Drug combination shows effectiveness in patients with recurrent ER-positive endometrial cancer

Drug combination shows effectiveness in patients with recurrent ER-positive endometrial cancer

Pembrolizumab significantly improved DFS versus placebo as adjuvant therapy in patients with stage IB-IIIA NSCLC regardless of PD-L1 expression

Pembrolizumab significantly improved DFS versus placebo as adjuvant therapy in patients with stage IB-IIIA NSCLC...

ICR welcomes OlympiA trial showing targeted drug improves survival in early-stage breast cancer with inherited BRCA1 or BRCA2 mutation

ICR welcomes OlympiA trial showing targeted drug improves survival in early-stage breast cancer with inherited...

A potential new target for cancer immunotherapies

A potential new target for cancer immunotherapies

Pioneering technique could unlock targeted treatments for cancer

Pioneering technique could unlock targeted treatments for cancer

Study reveals how to activate the immune system’s natural killer cells to protect against cancer and other diseases

Study reveals how to activate the immune system’s natural killer cells to protect against cancer and other diseases

Sequencing of drug combinations could amplify the anti-tumour immune response in liver cancer

Sequencing of drug combinations could amplify the anti-tumour immune response in liver cancer

More from ecancer